Observational studies on prophylaxis of hepatitis B virus reactivation with long or short course oralAgents among patients with acute myeloidleukemia
Journal Title: Preventive Medicine Research - Year 2014, Vol 3, Issue 1
Abstract
Background and purpose:hepatitis B virus (HBV) reactivation is one of serious complications among patients with acute myeloid LeukeMia (AML) following cytotoxic induction and consolidation chemotherapy.Nucleoside analogs including lamivudine and entecavir have been widely used as prophylactic or preemptive treatment for HBV reactivation.This study is to investigate clinical efficacy and safety of a long or short course oral ANTI-HBV for agents HBV reactivation in AML patients with HBV infection during chemotherapy.Methods:themedical records AML patients with HBV infection receiving aT least 4 courses of chemotherapy were Fund-funded:Department of theNineth People's Hospital affiliated to Shanghai Jiaotong University Medical School Fusion Fund(yard Fusion2017)Communications Author:LiuYanE-mail:ybb539355@163. com The retrospectively identified and systematically analyzed.These patients were further divided into four groups according to their hepatitis B surface antigen (HBsAg) status prior to initiation of chemotherapy and duration of prophylactic therapy.Reactivation of HBV and toxicity profiles of oral antiviral agents were systematically analyzed and compared among differeNT groups. Results:HBV reactivation and documented hbv-related hepatitis were Significantly lower in AML patients under long course antiviral prophylaxis (i.e. continuing oral antiviral therapy for at least 6 months after cessation of chemotherapy, LCP group) than in the patients with short course antiviral (i.e. continuing oral antiviral therapy for one month after cessation of chemotherapy, SCP Group), which was 5.56% (1/18) And0%(0/18) compared with 45.45% (5/11) and 36.36% (4/11) (p=0.018 and p=0.014). There was little difference in the incidence of antiviral resistance between LCP and SCP groups [11.11% (2/18) V5 9.09% (1/11), p>0.05].Furthermore, the rates of HBV reactivation and hbv-related hepatitis were significantly lower in AML patients with PositivE-HBsAg (HBsAg ^0.05 iu/ml) under long course antiviral prophylaxis than in HBsAg positive patients who received short couRSE antiviral agents [8.33% (1/12) and0%(0/12) V5 66.67% (4/6) and 66.67% (4/6), p=0.022 and p=0.005].Meanwhile, there was little difference in the rates of antiviral resistance-LCP and SCP between groups HBsAg amonge patients [8.33% (1/12) V5 16.67% (1/6), p>0.05].In addition, the rates of HBV reactivation and hbv-related hepatitis as so as antiviral resistance were shown to have LiTtle difference in AML patients with negative HBsAg (hbsag<0.05 iu/ml) between LCP and SCP groups.Concerning antiviral agent toxicity, no grade 3-4 toxicity occurred in patients from LCP or SCP group.Conclusion:Long course prophylaxis with oral antiviral agent appears to be an effective and tolerated preventative approach for reducing risks of HBV reactivation and associated events in AML pAtients with positive HBsAg during chemotherapy, which serves as a platform for the design of prospective clinical.
Authors and Affiliations
Zhuang yan, Tang yong, Yu yehua, Hang haifang, Ye weide Liu juan
Keywords
Related Articles
- EP ID EP680360
- DOI -
- Views 146
- Downloads 0
Observation on the efficacy of pneumatic therapeutic apparatus in preventing deep venous thrombosis of lower extremity in long-bed elderly patients
MeshExploreThe effect ofpneumatic therapeutic instrument on preventionof deep venous thrombosis of lower extremity in elderly patients with long periodFruit.Thesquaremethod2012Years2monthto2013Years6Month106elderly patie...
Prevention of bile Pai Shi decoction Therapeutic effect of biliary calculi recurrence after stone extraction
Objective to explore the therapeutic effect and application value of bile duct stone decoction in preventing and treating biliary calculi recurrence after stone extraction operation.method selection 2015 year 1 Month ~9...
Preventive application of liver-protecting drugs in the treatment of pulmonary tuberculosis
Purpose to improve the therapeutic effectiveness of TB patients , guarantee that the course is Benefit Complete . method Test Group 2so Patients with pulmonary tuberculosis were treated with liver-protecting drugs at the...
Clinical Effect analysis on indomethacin suppositories prevention of POST-ERCP acute pancreatitis
ObjectiveToinvestigate the clinical effect of indomethacin suppositories prevention of POST-ERCP acute. Pancreatitis20>Methods180 cases of ERCP were selected from March to September 2015 in ourHospital, all the patients...
Observational studies on prophylaxis of hepatitis B virus reactivation with long or short course oralAgents among patients with acute myeloidleukemia
Background and purpose:hepatitis B virus (HBV) reactivation is one of serious complications among patients with acute myeloid LeukeMia (AML) following cytotoxic induction and consolidation chemotherapy.Nucleoside analogs...